28.12.2013 Views

LIVE POLIO IRUS VACCINES

LIVE POLIO IRUS VACCINES

LIVE POLIO IRUS VACCINES

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Minnesota Studies With Oral Poliomyelitis Vaccine<br />

171<br />

DISCUSSION<br />

Using the time interval of about three weeks<br />

between feedings of the three types of poliovirus,<br />

it appears, as judged by virus isolations, that<br />

Type 1 replaced Type 2 and' Type 3 replaced<br />

Type 1 very well (see Figure 1). The presence<br />

of one virus is usually expected to interfere with<br />

the establishment of another virus. Since there<br />

was a time lapse of about one week between the<br />

collection of the stool specimens and the later<br />

feeding of another type, actual replacement is<br />

not proven but is strongly suggested by the evidence<br />

presented and is a most striking phenomenon.<br />

The continued excretion of Type 3 poliovirus<br />

in group B individuals, as shown by isolation<br />

from the fifth and sixth stool specimens, is<br />

in marked contrast to the small amount of continued<br />

excretion of Types 2 and 1 poliovirus when<br />

followed by the feeding of another type. This<br />

long excretion may be a characteristic of the Type<br />

3 vaccine strain and it is not known whether it<br />

would have been well replaced if fed ahead of<br />

Types 1 or 2. The possibility must also be considered<br />

that the long continued excretion was observed<br />

because no other virus was fed and therefore<br />

there was less competition for lebensraum.<br />

The absence of "wild" poliovirus in this community<br />

was demonstrated by the absence of poliovirus<br />

in the stool specimens collected prior to<br />

feeding the vaccine strains and by the sequential<br />

appearance of each type of poliovirus in stool<br />

specimens only after each specific type had been<br />

fed. Since only 16 cytopathogenic agents (adeno<br />

Types 1 and 2) other than poliovirus were isolated<br />

during this study the possible effect of enteric<br />

viruses other than poliovirus in interfering<br />

with the establishment of the vaccine strains of<br />

poliovirus has not been measured.<br />

The number of isolations shown for group B<br />

individuals in Fig. 1 is not an accurate measure<br />

of all of the persons who excreted virus. The<br />

specimens were collected about two weeks after<br />

virus feeding and it can be assumed that additional<br />

group B individuals excreted virus for<br />

shorter periods of time. This assumption is supported<br />

by the previously published results showing<br />

antibody response' which occurred for each<br />

type in a larger proportion of the individuals<br />

than those yielding virus in the stool specimen<br />

collected two weeks after feeding. The value of<br />

the isolation rates shown in Fig. 1 is therefore<br />

limited to a comparison of the differences in<br />

amounts of virus of each type available for community<br />

spread rather than as a graphic representation<br />

of the total number of excretors in the<br />

community.<br />

The difference in the amount of spread observed<br />

with the three types is probably related to<br />

the number of susceptibles in the community.l<br />

Considering susceptibles as those without antibody,<br />

the smallest number were susceptible to<br />

Type 2, and Type 2 spread the least; the largest<br />

number were susceptible to Type 3, and Type 3<br />

spread the most. The difference in observed<br />

spread of Types 1 and 3 was small, but as has<br />

been pointed out, we have reason to believe that<br />

the spread of Type 3 was less completely measured<br />

in this study than were the spread of Types<br />

1 and 2.<br />

The presence of antibody in the pre-feeding<br />

blood serum specimen does not always indicate<br />

protection against the vaccine strains becoming<br />

established in the intestinal tract (see Table 7).<br />

It has previously been established by several investigators<br />

that Salk vaccine is not effective in<br />

preventing multiplication of poliovirus in the intestinal<br />

tract. It also appears to be true that<br />

Salk vaccine induced antibodies are not effective<br />

in preventing multiplication of the vaccine<br />

strains of poliovirus used in this study (see Table<br />

7). In the absence of detectable poliovirus antibodies,<br />

prior Salk experience does not markedly<br />

reduce the virus isolation rates in either adults<br />

or children. Differences in natural and Salk induced<br />

antibodies cannot be determined, but it is<br />

logical to assume that poliovirus antibodies are<br />

more often natural in origin in adults than in<br />

children. On the basis of this assumption the<br />

differences in virus isolation rates observed in<br />

adults and children who have detectable antibodies<br />

and Salk experience is explainable (see<br />

Table 7, last column). If the poliovirus antibodies<br />

in the majority of the adults were natural<br />

in origin the low rates of virus isolation which<br />

were obtained (2.1 per cent to 7.1 per cent for the<br />

various types) are to be expected; in a larger<br />

proportion of the children showing antibodies<br />

these antibodies can be assumed to be Salk induced<br />

because the virus isolation rates are higher<br />

(7.9 per cent to 43.1 per cent). It follows that

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!